Mona Nili, PharmD, PhD
Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, Connecticut
Original Research
The Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US
August 11, 2025
Medical Expenditure Panel Survey data showed that over half of adults with schizophrenia report cognitive impairments, which were associated with higher healthcare costs and lower quality of life.